Abstract
At the present time, there is no widely agreed definition of postprandial lipaemia (PPL). This lack of a shared definition limits the identification and treatment of patients with exaggerated PPL as well as the evaluation of potential therapeutic agents. PPL is a complex syndrome characterized by non-fasting hypertriglyceridaemia that is associated with an increased risk of vascular events. This review considers the definition of PPL and the methodology for assessing this process.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Current Vascular Pharmacology |
| Vol/bind | 9 |
| Udgave nummer | 3 |
| Sider (fra-til) | 292-301 |
| Antal sider | 10 |
| ISSN | 1570-1611 |
| Status | Udgivet - 2011 |